secoisolariciresinol has been researched along with Hyperplasia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fabian, CJ; Hughes, JR; Johnson, KA; Khan, QJ; Kimler, BF; Klemp, JR; Metheny, T; Petroff, BK; Phillips, TA; Setchell, KD; Sharma, P; Yeh, HW; Zalles, CM; Zhao, X | 1 |
1 trial(s) available for secoisolariciresinol and Hyperplasia
Article | Year |
---|---|
Reduction in Ki-67 in benign breast tissue of high-risk women with the lignan secoisolariciresinol diglycoside.
Topics: Adult; Breast; Butylene Glycols; Enzyme-Linked Immunosorbent Assay; Estradiol; Female; Humans; Hyperplasia; Immunohistochemistry; Ki-67 Antigen; Lignans; Mammography; Middle Aged; Phytoestrogens; Pilot Projects; Premenopause; Progesterone; Risk Factors; Testosterone | 2010 |